EBITDA for HCA Healthcare (HCA)
According to HCA Healthcare's latest reported financial statements, the company's current EBITDA (TTM) is $15.66B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$15.66B
YoY change
+12.3%
5Y CAGR
+9.9%
Peak year (1998)
$18.68B
Cumulative EBITDA
$261.31B
EBITDA history chart for HCA Healthcare (HCA) from 1990 to 2025
EBITDA history table for HCA Healthcare (HCA) from 1990 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $15.60B | +12.3% | ||
| 2024 | $13.90B | +9.2% | ||
| 2023 | $12.72B | -4.3% | ||
| 2022 | $13.29B | -6.7% | ||
| 2021 | $14.25B | +46.4% | ||
| 2020 | $9.73B | +0.7% | ||
| 2019 | $9.66B | +3.2% | ||
| 2018 | $9.37B | +14.2% | ||
| 2017 | $8.20B | -3.3% | ||
| 2016 | $8.48B | +12.7% | ||
| 2015 | $7.53B | +6.8% | ||
| 2014 | $7.04B | +7.6% | ||
| 2013 | $6.55B | +2.8% | ||
| 2012 | $6.37B | -9.8% | ||
| 2011 | $7.06B | +22.9% | ||
| 2010 | $5.75B | +6.2% | ||
| 2009 | $5.41B | +17.5% | ||
| 2008 | $4.61B | -4.6% | ||
| 2007 | $4.83B | +20.5% | ||
| 2006 | $4.01B | -4.1% | ||
| 2005 | $4.18B | +10.4% | ||
| 2004 | $3.79B | -6.3% | ||
| 2003 | $4.04B | +31.2% | ||
| 2002 | $3.08B | -6.4% | ||
| 2001 | $3.29B | -81.3% | ||
| 2000 | $17.59B | +0.3% | ||
| 1999 | $17.53B | -6.2% | ||
| 1998 | $18.68B | +555.2% | ||
| 1997 | $2.85B | -29.4% | ||
| 1996 | $4.04B | +11.6% | ||
| 1995 | $3.62B | +71.0% | ||
| 1994 | $2.12B | +6.8% | ||
| 1993 | $1.98B | +2407.0% | ||
| 1992 | $79.10M | +87.0% | ||
| 1991 | $42.30M | +45.4% | ||
| 1990 | $29.10M | — |
EBITDA values are taken from HCA Healthcare's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, HCA Healthcare (HCA) EBITDA totalled $15.60B – grew 12.3% year-over-year.
HCA Healthcare EBITDA compound annual growth for the 2020–2025 (5 years) window is +9.9%, sustaining 2 straight years of year-over-year growth.
Between 1998 and 2025, HCA Healthcare EBITDA declined 16.5%, falling from $18.68B to $15.60B.
$18.68B stands as the all-time-high annual EBITDA, posted in 1998, against a low of $29.10M during 1990.
HCA Healthcare (HCA) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.
HCA Healthcare EBITDA by Year
HCA Healthcare EBITDA 2025: $15.60B
HCA Healthcare EBITDA in 2025 was $15.60B, grew 12.3% from 2024.
HCA Healthcare EBITDA 2024: $13.90B
HCA Healthcare EBITDA in 2024 was $13.90B, grew 9.2% from 2023.
HCA Healthcare EBITDA 2023: $12.72B
HCA Healthcare EBITDA in 2023 was $12.72B, edged down 4.3% below 2022.
HCA Healthcare EBITDA 2022: $13.29B
HCA Healthcare EBITDA in 2022 was $13.29B, declined 6.7% below 2021.
HCA Healthcare EBITDA 2021: $14.25B
HCA Healthcare EBITDA in 2021 was $14.25B.
See more financial history for HCA Healthcare (HCA).
Sector peers — EBITDA
Companies in the same sector as HCA Healthcare, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is HCA Healthcare's EBITDA?
- Latest reported EBITDA for HCA Healthcare (HCA) is $15.66B (period ending March 31, 2026).
How has HCA Healthcare EBITDA changed year-over-year?
- HCA Healthcare (HCA) EBITDA changed +12.3% year-over-year on the latest annual filing.
What is the long-term growth rate of HCA Healthcare EBITDA?
- HCA Healthcare (HCA) EBITDA compound annual growth rate is +9.9% over the most recent 5 years available.
When did HCA Healthcare EBITDA hit its highest annual value?
- HCA Healthcare EBITDA reached its highest annual value of $18.68B in 1998.
What was HCA Healthcare EBITDA in 2024?
- HCA Healthcare (HCA) EBITDA in 2024 was $13.90B.
What was HCA Healthcare EBITDA in 2025?
- HCA Healthcare (HCA) EBITDA in 2025 was $15.60B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
HCA Overview
Company profile, financial tools, and key metrics
HCA Revenue Counter
Earns $2,422 every second. See per minute, hour, and day.
HCA Earnings Counter
Earns $215.44 per second net profit. See per minute, hour, and day.
HCA Economic Scale
Exceeds Belarus's GDP. Compare with world economies.
HCA What If Invested
What if you had invested $1,000? See historical returns from any date.
HCA How It Makes Money
Discover visual breakdown of $76.39B in revenue — where it comes from and where it goes.
HCA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HCA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HCA Daily Price Character
Balanced · 52.3% historical win rate (green days). Streaks & record days.
HCA Buybacks
8.51% TTM buyback yield. Shareholder yield & SBC comparison.
HCA Dividend Profile
Yield: 0.68%. Safety: 5/7. See full history.
HCA Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
HCA Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.